Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 446

Results For "MS"

5457 News Found

Johnson & Johnson India launches ‘Be The Change For TB’ initiative
Public Health | March 24, 2022

Johnson & Johnson India launches ‘Be The Change For TB’ initiative

#BeTheChangeForTB is a public awareness initiative under the Corporate TB Pledge and aims to create a cadre of Youth Changemakers who can act as catalysts of change to help eliminate TB from India


MedisimVR raises Rs 3.5 cr. in Pre-Series A round led by Inflection Point Ventures
Startup | March 24, 2022

MedisimVR raises Rs 3.5 cr. in Pre-Series A round led by Inflection Point Ventures

MedisimVR is a VR based medical education platform for doctors, nurses & allied health professionals. It aims to make comprehensive Virtual Reality medical simulation more accessible and affordable


HaystackAnalytics sees alarming rise in TB cases
Healthcare | March 24, 2022

HaystackAnalytics sees alarming rise in TB cases

A staggering 65% of the TB cases in India are in the 15-45 age group


Seven ways the pharma industry can benefit from tech-driven logistics solutions
Opinion | March 24, 2022

Seven ways the pharma industry can benefit from tech-driven logistics solutions

The next-gen logistics management solutions are making the global supply chains more customer-centric and sustainable


Clinical Trials in the New Normal
Opinion | March 24, 2022

Clinical Trials in the New Normal

The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay


LifeMine Therapeutics and GSK enter drug discovery and development alliance
Biotech | March 24, 2022

LifeMine Therapeutics and GSK enter drug discovery and development alliance

The collaboration will utilize Avatar-Rx, LifeMine’s proprietary genomically-enabled drug discovery platform to access evolutionarily derived lead small molecules


USFDA approves Novartis Pluvicto to treat prostrate cancer
Drug Approval | March 24, 2022

USFDA approves Novartis Pluvicto to treat prostrate cancer

USFDA also approved complementary diagnostic imaging agent, Locametz, after radiolabeling with gallium-68 for the identification of PSMA-positive lesions


Akron BioProducts and Vor Bio to develop and cGMP manufacture of nucleases
Biotech | March 23, 2022

Akron BioProducts and Vor Bio to develop and cGMP manufacture of nucleases

This collaboration strengthens Akron’s portfolio of off-the-shelf gene-editing technologies while broadening Vor Bio’s collection of nucleases to engineer gene-modified cell therapies


Orgenics to conduct toxicology study on its intransal COVID-19 vaccine candidate
Biotech | March 23, 2022

Orgenics to conduct toxicology study on its intransal COVID-19 vaccine candidate

Data to establish the safety profile and human dose of vaccine candidate


Paige launches AI software to detect breast cancer metastases in lymph nodes
Digitisation | March 23, 2022

Paige launches AI software to detect breast cancer metastases in lymph nodes

Paige Breast Lymph Node designed to enhance diagnostic accuracy and confidence detecting breast cancer metastases of any size in lymph node tissue